Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month resultsRobert E. Coleman, Nigel Bundred, John Forbes et al.|Annals of Oncology|2012Cited by 337
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyHolger Eidtmann, Robert E. Coleman, Richard de Boer et al.|Annals of Oncology|2010Cited by 280
Pain outcomes in patients with advanced breast cancer and bone metastasesCharles S. Cleeland, Karen Chung, Jean‐Jacques Body et al.|Cancer|2012Cited by 155
A Comparison of Denosumab Versus Zoledronic Acid for the Prevention of Skeletal-Related Events in Breast Cancer Patients with Bone Metastases.Alison Stopeck, Ada Braun, Richard de Boer et al.|Cancer Research|2009Cited by 21